Skip to main content
Premium Trial:

Request an Annual Quote

Product Watch: DNA Software's qPCR CopyCount


DNA Software this week announced the general release of qPCR CopyCount, a cloud-based service that derives absolute DNA quantification from quantitative PCR sample data without the need for calibration standards.

The product is based on proprietary technology developed by DNA Software in which the shape of a qPCR curve is analyzed to accurately predict the absolute number of DNA copies in the original sample. This is based on a concept called counting PCR, in which the number of DNA copies at each PCR cycle is determined.

The quantification of DNA using qPCR CopyCount has important applications in nucleic acid-based diagnostics, gene expression studies, viral titer determination, cancer diagnostics, and next-generation sequencing, DNA Software said.

Joseph Johnson, vice president of business development at DNA Software, said in a statement that "researchers will observe a significant savings of laboratory resources as qPCR CopyCount is compatible with most existing qPCR instruments on the market, negating the need to purchase new instrumentation … to quantify DNA copies in a sample.

In addition, the cloud-based service lets researchers more quickly process very large PCR data sets so that experimental results can be immediately applied toward research, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.